Featured in
“This biotech start-up is working overtime to develop a second-wave, mutation-resistant Covid-19 vaccine”
— CNBC
Group run by former Google CEO to hold meeting with VCs, philanthropists about ways to fight coronavirus
— CNBC
“This biotech start-up is working overtime to develop a second-wave, mutation-resistant Covid-19 vaccine”
— CNBC
Group run by former Google CEO to hold meeting with VCs, philanthropists about ways to fight coronavirus
— CNBC